Zhejiang Taotao Vehicles (301345.SZ): The Listing Committee of the Hong Kong Stock Exchange has reviewed the company's H-share listing application.
Taotao Automotive (301345.SZ) announced that the sponsor for its H-share listing has received a letter from the Hong Kong Stock Exchange on September 4, 2026, which states that the listing committee of the Hong Kong Stock Exchange has reviewed the company's listing application. However, this letter does not constitute formal approval for the listing, and the Hong Kong Stock Exchange still has the authority to provide further comments on the company's listing application.
Zhejiang Taotao Vehicles (301345.SZ) announced that the sponsor for its H-share listing has received a letter from the Hong Kong Stock Exchange on September 4, 2026, which indicates that the Listing Committee of the Hong Kong Stock Exchange has reviewed the company's listing application. However, the letter does not constitute formal approval for the listing, and the Hong Kong Stock Exchange retains the authority to provide further comments on the company's listing application.
Related Articles
Hybio Pharmaceutical (300199.SZ): Carboprost Tromethamine Injection has obtained a drug registration certificate.
HAOHAI BIOTEC (06826) spent approximately HKD 1.0963 million to repurchase 65,500 shares on September 7.
Jintuo Technology (603211.SH) has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific individuals.
Hybio Pharmaceutical (300199.SZ): Carboprost Tromethamine Injection has obtained a drug registration certificate.
HAOHAI BIOTEC (06826) spent approximately HKD 1.0963 million to repurchase 65,500 shares on September 7.
Jintuo Technology (603211.SH) has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific individuals.
RECOMMEND
